A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinoma - PubMed (original) (raw)

A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinoma

Kimberley MacDonald et al. Cancer Epidemiol. 2009 Jul.

Abstract

Background: To investigate potential biologic mechanisms underlying the association between obesity and risk for esophageal adenocarcinoma (EADC), we studied the frequency of a common polymorphism of the insulin-like growth factor I receptor (IGF-IR) gene in patients with either gastroesophageal reflux disease (GERD), premalignant Barrett esophagus (BE) and or invasive EADC.

Methods: Using a well characterized series of 431 individuals enrolled in a case-control study, we studied the frequency of the IGF-IR gene polymorphism, G1013A.

Results: On multivariate analysis controlling for age and gender, in comparison to asymptomatic controls, obese individuals with the polymorphic A-variant (G/A, A/A) were found to have significantly increased risk for EADC (OR 4.81; 95%CI 1.09-21.15), whereas obese individuals with the G/G variant were not at statistically significant increased risk (OR 2.69; 95%CI 0.41-17.62). Similarly, compared to asymptomatic controls, only obese individuals with the A-variant (G/A, A/A) were at increased risk for BE (OR 3.11; 95%CI 1.12-8.63), while obese individuals with the G/G variant were not at increased risk for BE (OR 2.91; 95%CI 0.69-12.15).

Conclusion: We conclude that the common IGF-IR gene polymorphism G1013A modulates the risk of obesity for EADC, an effect most likely mediated by altered the receptor function by influencing gene transcription or mRNA stability. These findings further implicate the insulin-like growth factor axis in the molecular pathogenesis of EADC, and represent a plausible mechanistic link underlying the association between obesity and malignancy.

PubMed Disclaimer

Cited by

Associations of Lifestyle and Genetic Risks with Obesity and Related Chronic Diseases in the UK Biobank: A Prospective Cohort Study.
Zhang Y, Li Y, Peila R, Wang T, Xue X, Kaplan RC, Dannenberg AJ, Qi Q, Rohan TE. Zhang Y, et al. Am J Clin Nutr. 2024 Jun;119(6):1514-1522. doi: 10.1016/j.ajcnut.2024.04.025. Epub 2024 Apr 25. Am J Clin Nutr. 2024. PMID: 38677521
The association between obesity factor and esophageal caner.
Chen Q, Zhuang H, Liu Y. Chen Q, et al. J Gastrointest Oncol. 2012 Sep;3(3):226-31. doi: 10.3978/j.issn.2078-6891.2012.026. J Gastrointest Oncol. 2012. PMID: 22943013 Free PMC article.
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma.
Rubenstein JH, Shaheen NJ. Rubenstein JH, et al. Gastroenterology. 2015 Aug;149(2):302-17.e1. doi: 10.1053/j.gastro.2015.04.053. Epub 2015 May 7. Gastroenterology. 2015. PMID: 25957861 Free PMC article. Review.
Genetic susceptibility to Barrett's oesophagus: Lessons from early studies.
Findlay JM, Middleton MR, Tomlinson I. Findlay JM, et al. United European Gastroenterol J. 2016 Aug;4(4):485-92. doi: 10.1177/2050640615611018. Epub 2015 Oct 13. United European Gastroenterol J. 2016. PMID: 27536357 Free PMC article. Review.
[Relationship of insulin-like growth factor receptor single nucleotide polymorphism (SNP) with platinum-based chemotherapy outcomes in advanced non-small cell lung cancer].
Chen Y, Shao H, Li H, Han L, Zhang X. Chen Y, et al. Zhongguo Fei Ai Za Zhi. 2012 Feb;15(2):65-71. doi: 10.3779/j.issn.1009-3419.2012.02.01. Zhongguo Fei Ai Za Zhi. 2012. PMID: 22336232 Free PMC article. Chinese.

A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinoma - PubMed (original) (raw)